Breaking News

Friday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Syndicate
Amyris files to sell 65.2M shares of common stock for holders  17:28
07/10/20
07/10
17:28
07/10/20
17:28
AMRS

Amyris

$4.42 /

+0.06 (+1.38%)

 
ShowHide Related Items >><<
AMRS Amyris
$4.42 /

+0.06 (+1.38%)

AMRS Amyris
$4.42 /

+0.06 (+1.38%)

12/12/19
Fly Intel: Top five analyst initiations
12/12/19 Oppenheimer
Amyris initiated with an Outperform at Oppenheimer with $8 price target
12/11/19 Oppenheimer
Amyris initiated with an Outperform at Oppenheimer
AMRS Amyris
$4.42 /

+0.06 (+1.38%)

AMRS Amyris
$4.42 /

+0.06 (+1.38%)

AMRS Amyris
$4.42 /

+0.06 (+1.38%)

Over a week ago
Hot Stocks
Amyris, AB Mauri North America announce multi-year agreement » 08:38
06/22/20
06/22
08:38
06/22/20
08:38
AMRS

Amyris

$3.92 /

+0.02 (+0.51%)

Amyris and AB Mauri North…

Amyris and AB Mauri North America jointly announced an exclusive multi-year agreement for the sale and purchase of Amyris' Purecane RebM zero-calorie sweetener for baking applications. This partnership is expected to transform the industrial baking sector in the US, Mexico and Canada markets by enabling AB Mauri's customers to produce reduced sugar baked goods with no loss of flavor, texture or product appeal. The collaboration signifies a promising beginning and catalyst for future growth opportunities for the Purecane brand, which launched in December 2019 following Amyris' introduction of its sweetener ingredient in December 2018.

ShowHide Related Items >><<
AMRS Amyris
$3.92 /

+0.02 (+0.51%)

AMRS Amyris
$3.92 /

+0.02 (+0.51%)

12/12/19
Fly Intel: Top five analyst initiations
12/12/19 Oppenheimer
Amyris initiated with an Outperform at Oppenheimer with $8 price target
12/11/19 Oppenheimer
Amyris initiated with an Outperform at Oppenheimer
AMRS Amyris
$3.92 /

+0.02 (+0.51%)

AMRS Amyris
$3.92 /

+0.02 (+0.51%)

AMRS Amyris
$3.92 /

+0.02 (+0.51%)

Over a month ago
Hot Stocks
Amyris receives GRAS validation for new health and nutrition ingredient » 08:36
05/14/20
05/14
08:36
05/14/20
08:36
AMRS

Amyris

$3.22 /

-0.04 (-1.23%)

Amyris' first health…

Amyris' first health and nutrition ingredient received a validation by a unanimous Panel of Medical Experts as Generally Recognized As Safe, or GRAS. Following this successful validation, Amyris will submit an application for FDA GRAS approval of this ingredient. The ingredient is currently not being named due to partner's requirements.

ShowHide Related Items >><<
AMRS Amyris
$3.22 /

-0.04 (-1.23%)

AMRS Amyris
$3.22 /

-0.04 (-1.23%)

12/12/19
Fly Intel: Top five analyst initiations
12/12/19 Oppenheimer
Amyris initiated with an Outperform at Oppenheimer with $8 price target
12/11/19 Oppenheimer
Amyris initiated with an Outperform at Oppenheimer
AMRS Amyris
$3.22 /

-0.04 (-1.23%)

AMRS Amyris
$3.22 /

-0.04 (-1.23%)

AMRS Amyris
$3.22 /

-0.04 (-1.23%)

Earnings
Amyris backs FY20 revenue growth view of 44%, consensus $246.44M » 08:36
05/08/20
05/08
08:36
05/08/20
08:36
AMRS

Amyris

$2.50 /

+0.17 (+7.30%)

Gross Margin is expected…

Gross Margin is expected to operate at greater than 60% of sales due to improved sales mix and lower unit costs. Adjusted EBITDA is expected to turn positive during Q4.

ShowHide Related Items >><<
AMRS Amyris
$2.50 /

+0.17 (+7.30%)

12/12/19
Fly Intel: Top five analyst initiations
12/12/19 Oppenheimer
Amyris initiated with an Outperform at Oppenheimer with $8 price target
12/11/19 Oppenheimer
Amyris initiated with an Outperform at Oppenheimer
Earnings
Amyris reports Q1 adj. EPS (28c), consensus (19c) » 08:34
05/08/20
05/08
08:34
05/08/20
08:34
AMRS

Amyris

$2.50 /

+0.17 (+7.30%)

Reports Q1 revenue $29M,…

Reports Q1 revenue $29M, consensus $34.51M. CEO John Melo stated, "We are pleased with our Q1 results for what is typically our lowest sales quarter of the year due to seasonality. We have seen limited impact to our business performance from COVID-19. During the month of April we delivered our best single month of consumer product sales. We are experiencing significant demand for our ingredients into cleaning products and personal care products. We are encouraged by the growth in our top and bottom-line performance and see continued opportunity with our strong portfolio of branded consumer products and functional ingredients. Our focus on higher margin product sales and reducing unit costs by adapting our supply chain are delivering strong results. At our current performance we expect to achieve positive operating cash performance by Q4. We remain committed to our current guidance and will update our view on the year as we get more visibility."

ShowHide Related Items >><<
AMRS Amyris
$2.50 /

+0.17 (+7.30%)

12/12/19
Fly Intel: Top five analyst initiations
12/12/19 Oppenheimer
Amyris initiated with an Outperform at Oppenheimer with $8 price target
12/11/19 Oppenheimer
Amyris initiated with an Outperform at Oppenheimer
Hot Stocks
Amyris receives approval for Purecane from Brazil and Canada regulators » 08:31
04/20/20
04/20
08:31
04/20/20
08:31
AMRS

Amyris

$2.28 /

+0.03 (+1.34%)

Amyris announced that it…

Amyris announced that it has received approval from both Brazilian and Canadian regulators to expand its distribution of its fermented sugarcane Reb M, branded as Purecane zero calorie sweetener in the US to both of these countries. Purecane Brand Sweetener, also known as fermented sugarcane Reb M, is a no calorie and zero glycemic sweetener that can be used as part of a healthy diet to reduce the intake of sugar, calories and carbohydrates.

ShowHide Related Items >><<
AMRS Amyris
$2.28 /

+0.03 (+1.34%)

12/12/19
Fly Intel: Top five analyst initiations
12/12/19 Oppenheimer
Amyris initiated with an Outperform at Oppenheimer with $8 price target
12/11/19 Oppenheimer
Amyris initiated with an Outperform at Oppenheimer
Over a quarter ago
Hot Stocks
Amyris says sales of Pipette branded hand sanitizer off to strong start » 07:32
04/13/20
04/13
07:32
04/13/20
07:32
AMRS

Amyris

$2.48 /

+0.04 (+1.64%)

Amyris announced the full…

Amyris announced the full market launch and sales of its Pipette branded hand sanitizer as of April 9th. Since its launch, the product has seen demand well above expectations prompting the search for expanded supply capacity with a short-term goal of reaching 1M units monthly. During the first three days after launch, Amyris sold in excess of $1.5M of hand sanitizer and continues to experience very strong demand. The company is donating 21,000 family size 32oz units to front line health care workers battling the COVID-19 crisis, including UCSF Benioff Children's Hospital, Kaiser Permanente, Alameda Hospital, Fairmont Hospital & Rehabilitation Center, Highland Hospital, John George Psychiatric Hospital, San Leandro Hospital, UCLA, Cedars Sinai; and Elmhurst Hospital, Mount Sinai, St Francis Hospital and New York Presbyterian Hospital. Amyris has already donated hand sanitizer to corporations, like Bloom Energy, which is refurbishing much needed ventilators for hospitals.

ShowHide Related Items >><<
AMRS Amyris
$2.48 /

+0.04 (+1.64%)

12/12/19
Fly Intel: Top five analyst initiations
12/12/19 Oppenheimer
Amyris initiated with an Outperform at Oppenheimer with $8 price target
12/11/19 Oppenheimer
Amyris initiated with an Outperform at Oppenheimer
Options
Largest borrow rate increases among liquid names » 08:45
04/06/20
04/06
08:45
04/06/20
08:45
CLVS

Clovis

$6.08 /

+0.04 (+0.66%)

, UPRO

Uproar Inc

$24.47 /

-1.12 (-4.38%)

, JNK

SPDR Barclays High Yield Bond

$90.55 /

-1.77 (-1.92%)

, I

Intelsat

$1.06 /

-0.12 (-10.21%)

, AMRS

Amyris

$2.25 /

-0.055 (-2.39%)

, SGMS

Scientific Games

$5.84 /

-1.42 (-19.56%)

, RSX

Market Vectors Russia ETF

$17.77 /

+0.31 (+1.78%)

, EWC

iShares MSCI Canada Index

$20.98 /

-0.17 (-0.80%)

, MNK

Mallinckrodt

$1.70 /

-0.1 (-5.56%)

Latest data shows the…

Latest data shows the largest indicative borrow rate increases among liquid option names include: Clovis (CLVS) 79.78% +1.85, ProShares UltraPro S&P 500 (UPRO) 3.49% +1.58, SPDR Barclays Capital High Yield Bond (JNK) 2.06% +0.51, Intelsat (I) 8.11% +0.35, Amyris (AMRS) 10.84% +0.30, Scientific Games (SGMS) 0.74% +0.29, Market Vectors Russia (RSX) 3.52% +0.28, iShares Canada (EWC) 1.44% +0.28, Direxion Daily 20 plus Year Treasury Bull 3X Shares (TMF) 4.07% +0.15, and Mallinckrodt (MNK) 66.18% +0.08.

ShowHide Related Items >><<
CLVS Clovis
$6.08 /

+0.04 (+0.66%)

02/25/20
Fly Intel: Top five analyst initiations
02/25/20 RBC Capital
Clovis initiated with an Outperform at RBC Capital
01/08/20 H.C. Wainwright
Clovis price target lowered to $27 from $36 at H.C. Wainwright
01/07/20 Piper Sandler
Clovis modestly extends cash runway with debt deal, says Piper Sandler
UPRO Uproar Inc
$24.47 /

-1.12 (-4.38%)

JNK SPDR Barclays High Yield Bond
$90.55 /

-1.77 (-1.92%)

I Intelsat
$1.06 /

-0.12 (-10.21%)

04/01/20 Goldman Sachs
Intelsat downgraded to Sell from Neutral at Goldman Sachs
03/27/20 Cowen
Intelsat downgraded to Market Perform at Cowen
03/27/20 Cowen
Intelsat downgraded to Market Perform from Outperform at Cowen
02/10/20 Raymond James
Intelsat risk/reward more fairly valued, says Raymond James
AMRS Amyris
$2.25 /

-0.055 (-2.39%)

12/12/19
Fly Intel: Top five analyst initiations
12/12/19 Oppenheimer
Amyris initiated with an Outperform at Oppenheimer with $8 price target
12/11/19 Oppenheimer
Amyris initiated with an Outperform at Oppenheimer
SGMS Scientific Games
$5.84 /

-1.42 (-19.56%)

02/20/20 Deutsche Bank
Scientific Games price target lowered to $23 from $29 at Deutsche Bank
02/19/20 Craig-Hallum
Scientific Games price target lowered to $55 from $60 at Craig-Hallum
02/19/20 Stifel
Stifel sees Scientific Games trading sharply lower after 'underwhelming' report
01/08/20 Stifel
Eldorado Resorts named top Gaming & Leisure idea for 2020 at Stifel
RSX Market Vectors Russia ETF
$17.77 /

+0.31 (+1.78%)

EWC iShares MSCI Canada Index
$20.98 /

-0.17 (-0.80%)

MNK Mallinckrodt
$1.70 /

-0.1 (-5.56%)

02/25/20 Stifel
Mallinckrodt clearing path for shares to be revalued, says Stifel
01/22/20 Wells Fargo
Revance, Amphastar named top 2020 Specialty Pharmaceuticals ideas at Wells Fargo
09/10/19 Stifel
Mallinckrodt's sale of BioVectra helps alleviate cash pressure, says Stifel
09/09/19 Stifel
Mallinckrodt price target lowered to $8 from $20 at Stifel
Hot Stocks
Amyris announces initial production of hands sanitizer at Allure Labs » 08:32
03/31/20
03/31
08:32
03/31/20
08:32
AMRS

Amyris

$2.46 /

+0.205 (+9.11%)

Amyris announced that…

Amyris announced that initial production of its hand sanitizer has started with Allure Labs as its contract manufacturing and packaging partner. Amyris has also successfully replenished its popular baby wipes that have been out of stock in most channels as fast as they restock. Last week, Amyris announced the launch of a new, safe and clean Pipette Baby branded hand sanitizer - that can be used by everyone - to help combat COVID-19. The company has rapidly scaled its manufacturing and supply chain to respond to the strong demand received since the announcement was made. Amyris is also announcing the successful restocking of its baby wipes that was sold out across most sales channels. The company has increased production orders to meet the increased need of consumers.

ShowHide Related Items >><<
AMRS Amyris
$2.46 /

+0.205 (+9.11%)

12/12/19
Fly Intel: Top five analyst initiations
12/12/19 Oppenheimer
Amyris initiated with an Outperform at Oppenheimer with $8 price target
12/11/19 Oppenheimer
Amyris initiated with an Outperform at Oppenheimer
Options
Largest borrow rate increases among liquid names » 08:45
03/27/20
03/27
08:45
03/27/20
08:45
OVV

Ovintiv

$2.84 /

+ (+0.00%)

, FCEL

FuelCell

$1.65 /

+0.08 (+5.10%)

, AMRS

Amyris

$2.16 /

+0.16 (+8.00%)

, PD

PagerDuty

$18.40 /

+0.08 (+0.44%)

, UVXY

ProShares Trust Ultra VIX Short Term Futures ETF

$59.48 /

-8.53 (-12.54%)

, BZUN

Baozun

$29.14 /

+1.35 (+4.86%)

, FSM

Fortuna Silver Mines

$2.68 /

-0.055 (-2.01%)

, SSO

ProShares Ultra S&P 500

$91.50 /

+9.44 (+11.50%)

, VGK

The Vanguard FTSE Europe ETF

$44.09 /

+2.13 (+5.08%)

Latest data shows the…

Latest data shows the largest indicative borrow rate increases among liquid option names include: Precigen (PGEN) 24.59% +1.87, Ovintiv (OVV) 49.23% +0.85, FuelCell (FCEL) 14.60% +0.23, Amyris (AMRS) 15.66% +0.20, PagerDuty (PD) 0.76% +0.19, ProShares Ultra VIX Short Term Futures (UVXY) 3.74% +0.16, Baozun (BZUN) 2.06% +0.16, Fortuna Silver Mines (FSM) 0.71% +0.16, ProShares Ultra S&P 500 (SSO) 1.95% +0.14, and Vanguard MSCI Europe (VGK) 0.84% +0.13.

ShowHide Related Items >><<
OVV Ovintiv
$2.84 /

+ (+0.00%)

03/16/20 RBC Capital
Ovintiv downgraded to Sector Perform from Outperform at RBC Capital
03/16/20 Goldman Sachs
Ovintiv downgraded to Neutral from Buy at Goldman Sachs
03/12/20 Credit Suisse
Ovintiv downgraded to Neutral from Outperform at Credit Suisse
03/11/20 Credit Suisse
Ovintiv downgraded to Neutral from Outperform at Credit Suisse
FCEL FuelCell
$1.65 /

+0.08 (+5.10%)

03/16/20 Craig-Hallum
FuelCell upgraded to Hold at Craig-Hallum
03/16/20 Craig-Hallum
FuelCell upgraded to Hold from Sell at Craig-Hallum
01/23/20 Craig-Hallum
FuelCell downgraded to Sell at Craig-Hallum
01/23/20 Craig-Hallum
FuelCell downgraded to Sell from Hold at Craig-Hallum
AMRS Amyris
$2.16 /

+0.16 (+8.00%)

12/12/19
Fly Intel: Top five analyst initiations
12/12/19 Oppenheimer
Amyris initiated with an Outperform at Oppenheimer with $8 price target
12/11/19 Oppenheimer
Amyris initiated with an Outperform at Oppenheimer
PD PagerDuty
$18.40 /

+0.08 (+0.44%)

03/19/20 RBC Capital
PagerDuty price target lowered to $22 from $30 at RBC Capital
12/06/19 SunTrust
PagerDuty price target lowered to $25 from $32 at SunTrust
12/06/19 DA Davidson
PagerDuty price target lowered to $24 from $36 at DA Davidson
12/06/19 RBC Capital
PagerDuty price target lowered to $30 from $43 at RBC Capital
UVXY ProShares Trust Ultra VIX Short Term Futures ETF
$59.48 /

-8.53 (-12.54%)

BZUN Baozun
$29.14 /

+1.35 (+4.86%)

11/22/19 Credit Suisse
Baozun downgraded to Neutral from Outperform at Credit Suisse
08/05/19 Jefferies
Baozun initiated with a Buy at Jefferies
FSM Fortuna Silver Mines
$2.68 /

-0.055 (-2.01%)

09/13/19 Canaccord
Fortuna Silver Mines upgraded to Buy from Hold at Canaccord
09/10/19 Scotiabank
Fortuna Silver Mines upgraded to Outperform from Sector Perform at Scotiabank
08/08/19 Canaccord
Fortuna Silver Mines downgraded to Hold from Buy at Canaccord
SSO ProShares Ultra S&P 500
$91.50 /

+9.44 (+11.50%)

VGK The Vanguard FTSE Europe ETF
$44.09 /

+2.13 (+5.08%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.